# Poster Session I - A82 VIP-SECRETING NEUROBLASTOMA AS A RARE CAUSE OF PERSISTENT SECRETORY DIARRHEA IN INFANCY

**Authors:** A Aljaafari, P Church

PMC · DOI: 10.1093/jcag/gwaf042.082 · Journal of the Canadian Association of Gastroenterology · 2026-02-13

## TL;DR

A 12-month-old girl with persistent watery diarrhea was diagnosed with a rare VIP-secreting neuroblastoma, highlighting the importance of timely diagnosis in infants with unexplained secretory diarrhea.

## Contribution

This case report presents a rare instance of VIP-secreting neuroblastoma in infancy, emphasizing its presentation with refractory secretory diarrhea and electrolyte disturbances.

## Key findings

- The infant's persistent diarrhea was attributed to a VIP-secreting neuroblastoma, a rare cause of secretory diarrhea in infancy.
- Despite various treatments, the patient required total parenteral nutrition and chemotherapy for management.
- MRI and biochemical tests confirmed the diagnosis of neuroblastoma with elevated urinary markers.

## Abstract

Secretory diarrhea in infancy is rare and can be associated with paraneoplastic syndromes such as vasoactive intestinal peptide (VIP)–secreting neuroblastoma. Less than 1% of patients with neuroblastoma have clinical evidence of VIP secretion, and in these rare cases, chronic secretory diarrhea may be one of the earliest presenting symptoms. Delay in recognition may result in severe electrolyte derangements and life-threatening complications.

To report a case of an infant presenting with intractable watery diarrhea ultimately attributed to a VIP-secreting neuroblastoma.

A 12-month-old girl presented with persistent watery, non-bloody diarrhea occurring several times per day, accompanied by poor oral intake, lethargy, vomiting, and ∼12% weight loss over 10 days. Initial admission identified adenovirus on stool PCR with partial improvement after correction of hypokalemia. Symptoms recurred shortly after discharge, with worsening diarrhea, severe hypokalemia (2.2 mmol/L), metabolic acidosis with a normal anion gap (4 mmol/L), and prolonged QTc, requiring pediatric intensive care for electrolyte repletion and monitoring.

Despite stabilization, she continued to pass 4–6 watery stools daily with persistent electrolyte losses and dependence on intravenous potassium supplementation. Stool electrolytes demonstrated a secretory pattern. Endoscopy was normal macroscopically and microscopically. MRI revealed a multilobulated retroperitoneal mass centered at the organ of Zuckerkandl with vascular encasement and foraminal extension, consistent with neuroblastoma. Urinary vanillylmandelic acid (16.4) and homovanillic acid (43.9) were elevated. Metaiodobenzylguanidine (MIBG) scintigraphy confirmed an avid abdominal lesion without distant metastases.

Despite trials of loperamide, atropine, and continuous octreotide infusion, stool output remained unchanged. In view of her ongoing weight loss and sustained dependence on intravenous fluid supplementation, total parenteral nutrition (TPN) was initiated to provide adequate nutritional support. She was subsequently transferred to the Oncology service, where systemic chemotherapy was commenced and is ongoing at the time of this report.

This case highlights a rare presentation of VIP-secreting neuroblastoma in infancy, characterized by refractory secretory diarrhea and profound electrolyte disturbances, including normal anion gap metabolic acidosis. Recognition of this association through appropriate imaging and biochemical testing is essential for timely diagnosis and initiation of disease-directed therapy in children with unexplained persistent diarrhea.

None

## Linked entities

- **Proteins:** VIP (vasoactive intestinal peptide)
- **Chemicals:** loperamide (PubChem CID 3955), atropine (PubChem CID 3661), octreotide (PubChem CID 448601), vanillylmandelic acid (PubChem CID 1245), homovanillic acid (PubChem CID 1738), metaiodobenzylguanidine (PubChem CID 60860)
- **Diseases:** neuroblastoma (MONDO:0005072), secretory diarrhea (MONDO:0000249), hypokalemia (MONDO:0003019), metabolic acidosis (MONDO:0000440)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12901575/full.md

---
Source: https://tomesphere.com/paper/PMC12901575